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Expression of Neuropeptide Galanin and Galanin Receptors in
Human Skin
To the Editor:
The neural system in human skin contributes to the
regulation of body homeostasis by transporting afferent
stimuli to the central nervous system. Efferent activities like
the modulation of inflammatory reactions, which are
partially mediated by neuropeptides released from neurons
in the skin, have also been detected (Scholzen et al, 1998).
One of these neuropeptides is galanin (GAL), a 29–30
amino-acid peptide (Tatemoto et al, 1983), which has been
shown to have a widespread distribution in the central and
peripheral nervous systems of many mammalian species
(Kordower et al, 1992).
In human skin, Johansson et al (1988) reported GAL-like
immunoreactivity (GAL-LI) in nerve terminals and fibers of
the dermis and sometimes in the basal layer of the
epidermis. Furthermore, the nerves beneath the epidermis,
around hair follicles, Meissner’s corpuscles, and sweat
glands were found to be immunoreactive for GAL (Tainio
et al, 1987; Johansson et al, 1999). Pincelli et al (1990) noted
a diffuse intracellular staining in the epidermis of human
skin, which they regarded as probably due to a cross-
reactivity of the antibody used. A first hint for extra-neuronal
expression of GAL in the skin was provided by Ji et al
(1995), who found GAL-LI and GAL mRNA in the dermis and
epithelium of the rat hindpaw. Recently, the expression of
GAL in the epithelium of the rat molar gingiva was reported
(Baumann et al, 2003). GAL exerts its diverse actions
via GAL receptors, which belong to the superfamily of
G-protein coupled transmembrane receptors. Three GAL
receptor subtypes (GalR1-3) have been cloned and phar-
macologically characterized to date (Branchek et al, 2000).
Although GAL receptors are the key to the functional
significance of GAL action, to our knowledge, their expres-
sion in human skin has not been studied to date.
We analyzed GAL-LI in human skin biopsies of different
anatomical sites, including the inner aspect of the upper
arm, temple, ear, thigh, and foreskin by immunohistochem-
istry. GAL-LI was detected in the follicular and interfollicular
epidermis with no apparent differences between basal and
suprabasal layers and anatomical sites (Fig 1A, C). In our
study, the specificity of the GAL-LI in the epidermis was
shown by absorption of the antibody with 1 mM GAL
peptide, which abolished the staining (Fig 1B, D).
The dermis of foreskin displayed GAL-LI-positive nerve
fiber bundles (Fig 1E, Table I). Arteries, small pre-capillary
arterioles, and capillaries in the foreskin were also GAL-LI-
positive (Fig 1E, Table I). Smooth muscle cells of the lamina
muscularis of the vessels are most likely creating this signal.
GAL-LI was also observed in ductal cells of eccrine sweat
glands but not in the cells of the secretory coil (Fig 1G). In
sebaceous glands, no specific GAL-LI could be detected.
In order to determine if GAL is a secretory product of
human keratinocytes, cell culture supernatants of primary
cultured keratinocytes from neonatal foreskins were ana-
lyzed for the presence of GAL-LI. GAL peptide elution, and
radioimmunoassays were performed according to Berger
et al (2002) (detection limit: 0.2 fmol GAL/1  106 cells per h).
GAL was secreted into the supernatant of primary cultured
keratinocytes at a rate of 0.84  0.33 fmol/1  106 cells per
h (n¼ 5), which leads to a steady-state level of 5.0  2.1
fmol per mL GAL in the cell culture supernatant after 18 h.
This amount is comparable to the GAL concentration found
in the serum of healthy humans (8 fmol per mL; Baranowska
et al, 1997).
[125I]-GAL receptor autoradiography was used to detect
GAL binding sites in different anatomical sites. In contrast to
GAL, no specific GAL binding sites were present in the
human epidermis of all sites (Fig 2A, B). GAL binding sites
could mainly be detected around eccrine sweat glands (Fig
2E, F). However, by the use of this method it cannot be
distinguished if the receptors are expressed on myoepithe-
lial cells or on surrounding nerve fibers. To a lesser extent,
GAL binding was found on nerve fibers and in the vicinity of
arteries and arterioles of foreskin (Fig 2C, D; Table I).
In this study, we show that GAL and GAL receptors are
expressed in human skin in a neuronal and extra-neuronal
position (Table I). This finding further strengthens the notion
that neuropeptides can also be expressed outside of the
nervous system to exert multiple biological functions,
including mitogenic and immunomodulatory effects. The
neuropeptide, which has been shown to be paradigmatic
for this dichotomy in human skin, is alpha-melanocyte
stimulating hormone (a-MSH), a proopiomelanocortin-
derived peptide. a-MSH exerts its effects via binding to
melanocortin receptors 1–5, being expressed on various
tissues including melanocytes, keratinocytes, fibroblasts,
and endothelial cells (for a review, see Scholzen et al
(1998)). In contrast, we could not find GAL binding sites on
keratinocytes and endothelial membrane preparations,
although GAL receptors have been reported to be
expressed in other epithelia, e.g. the human intestinal
epithelium (Engelis et al, 1998; Berger et al, 2003). Most
likely GAL being expressed and secreted by keratinocytes
Abbreviations: a-MSH, alpha-melanocyte stimulating hormone;
GAL, galanin; GAL-LI, GAL-like immunoreactivity; PBS, phos-
phate-buffered saline
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Figure 1
GAL immunohistochemistry on skin cryostat sections performedwith an antibody against GAL (A, C, E, G) and antiserum pre-absorbed with 1 lM
human GAL peptide (B, D, F, H). Normal human skin was obtained from healthy volunteers after informed consent, immediately frozen on dry ice, and
stored at 801C until use. Cryosections of skin specimens (4 mm) were air dried and fixed in 4% formaldehyde for 10 min and washed with 1  PBS.
Immunostaining was performed according to the protocol of Level 2 USA Ultra Streptavidin Detection System (Signet Laboratories, Dedham,
Massachusetts) with the GAL antibody (kindly provided by Prof. Ken K. Ho, Garvan Institute of Medical Research, Sydney), diluted 1/1500 in PBS. GAL-LI
could be detected in the epidermis of human foreskin (A, B), hair follicles in the dermis of the inner upper arm (C, D), nerve fibers and blood vessels of the
dermis of foreskin (E, F) and ductal cells of eccrine sweat glands of the inner upper arm (G, H). Scale bar¼50 mm. (bv, blood vessel; n, nerve fiber bundle; hf,
hair follicle; sg, sweat gland).
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Table I. Expression of GAL-LI and GAL binding sites in the human skin
GAL-LIa [125I]-GAL bindingb
Interfollicular epidermis þ þ 
Follicular epidermis þ þ 
Fibroblasts  
Dermal arteries/arterioles þ (smooth muscle cells) þ (most likely innervating nervesc)
Dermal venules  
Sweat glands þ þ (ductal cells) þ þ (most likely innervating nervesc)
þ (innervating nerves; this study and Tainio et al, 1987)
Nerve fibers þ (this study and Johansson et al, 1988, 1999; Pincelli et al, 1990) þ
Sebaceous glands  
Merkel cells þ (Fantini and Johansson, 1995) n.d.
aFor GAL-LI also references to previous studies are given.
bGAL binding sites were determined by receptor autoradiography as described in Fig 2.
cCurrently, no distinction can be made if this labeling is due to nerves innervating these structures or due to receptors on these cells.
þ þ , strong staining;þ , moderate staining;, no staining; n.d., not determined.
Figure 2
Distribution of GAL binding sites in human skin specimens. Binding of [125I]-labeled GAL to cryostat sections (12 mm) of freshly frozen human
skin specimens was carried out according to Berger et al (2002). Black grains represent GAL receptor-positive areas (A, C, E). Total displacement
represents non-specific binding in the presence of an excess of unlabeled (1 mM) GAL (B, D, F). (A, B) epidermis of foreskin; (C, D) dermis of foreskin;
(E, F) eccrine sweat glands of the inner upper arm. Scale bar¼50 mm (bv, blood vessel; sg, sweat gland).
1052 LETTER TO THE EDITOR THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
exerts its actions on the skin nervous system, by diffusion
into the dermis or via the vascular system.
A possible role of GAL in the regulation of vasomotoric
action is suggested by Santha et al (1998, 1999). Expression
of GAL on smooth muscle cells of the lamina muscularis of
small vessels and GAL receptors in nervous tissue surround-
ing small arterioles supports the idea of a modulatory action
in vasodilatation and therefore neurogenic inflammation.
GAL-LI surrounding sweat glands were consistent with
GAL-positive nerve fibers innervating the glands as reported
previously (Tainio et al, 1987). Intriguingly, GAL-LI was found
to be restricted to ductal cells. Other neuropeptides found
in sweat glands were mainly found to be localized in the
secretory coil (Zancanaro et al, 1999) and are therefore
regarded to be secreted into the lumen. Being located in the
ductal cells GAL could function in a regulatory feedback
loop upon secretion of sweat by targeting of GAL receptors
and consecutively activation/inactivation of sweat gland
function. Taken together, these studies suggest a possible
role of GAL in skin physiology.
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